ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,388Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 403

$689K Total Retail Price of All Prescriptions

Rank: 19 out of 403

483 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 8,500 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 453 347 1 2
LISINOPRIL 409 342 2 1
LEVOTHYROXINE SODIUM 325 234 3 3
OMEPRAZOLE 322 244 4 9
HYDROCHLOROTHIAZIDE 315 226 5 6
METOPROLOL TARTRATE 277 223 6 10
AMLODIPINE BESYLATE 277 247 6 4
METFORMIN HCL 256 233 8 8
METOPROLOL SUCCINATE 252 216 9 11
FUROSEMIDE 240 197 10 7
ATORVASTATIN CALCIUM 218 190 11 5
CITALOPRAM HBR 195 137 12 22
GABAPENTIN 182 136 13 17
LANTUS 168 108 14 54
WARFARIN SODIUM 165 151 15 12
POLYETHYLENE GLYCOL 3350 137 90 16 60
ATENOLOL 136 96 17 13
ZOLPIDEM TARTRATE 133 95 18 16
LOSARTAN POTASSIUM 122 120 19 21
BACLOFEN 118 41 20 110
ALLOPURINOL 117 91 21 31
HYDROCODONE-ACETAMINOPHEN 112 78 S3 22 15
SERTRALINE HCL 107 92 23 20
MIRTAZAPINE 107 71 23 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 85 25 29
CYMBALTA 98 93 26 43
ADVAIR DISKUS 95 77 27 33
QUETIAPINE FUMARATE 94 77 28 52
SPIRIVA 92 82 29 35
TRAZODONE HCL 90 88 30 25
LIPITOR 78 62 31 53
DONEPEZIL HCL 77 66 32 23
TAMSULOSIN HCL 76 62 33 27
GENERLAC 73 69 34 154
PREDNISONE 69 46 35 34
PHENYTOIN SODIUM EXTENDED 68 50 36 166
NEXIUM 67 47 37 18
ISOSORBIDE MONONITRATE ER 65 44 38 62
TRAMADOL HCL 63 61 39 28
RANITIDINE HCL 63 49 39 46
JANUVIA 62 59 41 44
ESCITALOPRAM OXALATE 61 38 42 36
FLUTICASONE PROPIONATE 60 43 43 47
POTASSIUM CHLORIDE 58 41 44 37
HUMALOG 57 34 45 151
MORPHINE SULFATE ER 54 28 S2 46 104
LOSARTAN-HYDROCHLOROTHIAZIDE 52 32 47 91
GENTAMICIN SULFATE 52 0 47 256
RAMIPRIL 51 51 49 75
DIOVAN 51 49 49 24
CARVEDILOL 50 49 51 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.